Skip to content
Recall Observatory FDA recall evidence

Device product

Burlington Medical, Caps.

Z-1760-2026

February 11, 2026

Class II

Product summary

Firm
Burlington Medical, LLC
Event
Event 98415
Status
Ongoing
Classification
Class II
Quantity
961 units
Official record key
device-enforcement:Z-1760-2026

Official wording

Reason: Potential for attenuation degradation over time, decreasing the lifespan.

Code information: All serial numbers are affected that were manufactured with Xenolite 800 attenuation material from 01/16/2025 to 01/21/2026. 1. Model Number: R8CAP; UDI-DI (Product Code): 00840331272185 (CAP8-R8CAP-LG_XL), 00840331272178 (CAP8-R8CAP-SM_MD). 2. Model Number: S8CAP; UDI-DI (Product Code): 00840331272208 (CAP8-S8CAP-LG_XL), 00840331272192 (CAP8-S8CAP-SM_MD). 3.Model Number: U8CAP; UDI-DI (Product Code): 00840331272222 (CAP8-U8CAP-LG_XL), 00840331272215 (CAP8-U8CAP-SM_MD).

Distribution pattern: Worldwide distribution. Nationwide distribution in the US and international distribution to Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand, Taiwan, Uruguay, and Vietnam.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Potential for attenuation degradation over time, decreasing the lifespan.